331 related articles for article (PubMed ID: 31136804)
21. [Two-dimensional zebrafish model combined with hyphenated chromatographic techniques for evaluation anti-osteoporosis activity of epimendin A and its metabolite baohuoside I].
Zhan Y; Wei YJ; Sun E; Xu FJ; Jia XB
Yao Xue Xue Bao; 2014 Jun; 49(6):932-7. PubMed ID: 25212043
[TBL] [Abstract][Full Text] [Related]
22. A Network Pharmacology Approach to Estimate the Active Ingredients and Potential Targets of Cuscutae semen in the Treatment of Osteoporosis.
Dai W; Sun Y; Zhong G
Med Sci Monit; 2020 Feb; 26():e920485. PubMed ID: 32081843
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of Bach1 protects osteoblasts against hydrogen peroxide-induced oxidative damage in vitro by enhancing the activation of Nrf2/ARE signaling.
Tian X; Cong F; Guo H; Fan J; Chao G; Song T
Chem Biol Interact; 2019 Aug; 309():108706. PubMed ID: 31194955
[TBL] [Abstract][Full Text] [Related]
24. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
Yang Y; Nian H; Tang X; Wang X; Liu R
J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
[TBL] [Abstract][Full Text] [Related]
25. MnTBAP inhibits bone loss in ovariectomized rats by reducing mitochondrial oxidative stress in osteoblasts.
Cao X; Luo D; Li T; Huang Z; Zou W; Wang L; Lian K; Lin D
J Bone Miner Metab; 2020 Jan; 38(1):27-37. PubMed ID: 31493249
[TBL] [Abstract][Full Text] [Related]
26. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis.
Huang Q; Gao B; Jie Q; Wei BY; Fan J; Zhang HY; Zhang JK; Li XJ; Shi J; Luo ZJ; Yang L; Liu J
Bone; 2014 Sep; 66():306-14. PubMed ID: 24933344
[TBL] [Abstract][Full Text] [Related]
27. Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification.
Luo L; Guan Z; Jin X; Guan Z; Jiang Y
Mol Med; 2023 Mar; 29(1):36. PubMed ID: 36941586
[TBL] [Abstract][Full Text] [Related]
28. Antiosteoporotic activity of Er-Xian Decoction, a traditional Chinese herbal formula, in ovariectomized rats.
Nian H; Qin LP; Zhang QY; Zheng HC; Yu Y; Huang BK
J Ethnopharmacol; 2006 Nov; 108(1):96-102. PubMed ID: 16765003
[TBL] [Abstract][Full Text] [Related]
29. In vivo screening for anti-osteoporotic fraction from extract of herbal formula Xianlinggubao in ovariectomized mice.
Wang X; He Y; Guo B; Tsang MC; Tu F; Dai Y; Yao Z; Zheng L; Xie X; Wang N; Yao X; Zhang G; Qin L
PLoS One; 2015; 10(2):e0118184. PubMed ID: 25695519
[TBL] [Abstract][Full Text] [Related]
30. Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts.
Wang Y; Zhao L; Wang Y; Xu J; Nie Y; Guo Y; Tong Y; Qin L; Zhang Q
Acta Biochim Biophys Sin (Shanghai); 2012 May; 44(5):431-41. PubMed ID: 22427460
[TBL] [Abstract][Full Text] [Related]
31. Porcine placenta hydrolysates enhance osteoblast differentiation through their antioxidant activity and effects on ER stress.
Lee HY; Chae HJ; Park SY; Kim JH
BMC Complement Altern Med; 2016 Aug; 16(1):291. PubMed ID: 27535035
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid-induced osteoporosis.
Xia T; Dong X; Lin L; Jiang Y; Ma X; Xin H; Zhang Q; Qin L
J Pharm Biomed Anal; 2019 Mar; 166():336-346. PubMed ID: 30690247
[TBL] [Abstract][Full Text] [Related]
33. Erxian Decoction Attenuates TNF-α Induced Osteoblast Apoptosis by Modulating the Akt/Nrf2/HO-1 Signaling Pathway.
Wang N; Xin H; Xu P; Yu Z; Shou D
Front Pharmacol; 2019; 10():988. PubMed ID: 31551787
[TBL] [Abstract][Full Text] [Related]
34. Integration of Zebrafish Model and Network Pharmacology to Explore Possible Action Mechanisms of Morinda officinalis for Treating Osteoporosis.
Fu SQ; Wang ZY; Jiang ZM; Bi ZM; Liu EH
Chem Biodivers; 2020 May; 17(5):e2000056. PubMed ID: 32190963
[TBL] [Abstract][Full Text] [Related]
35. Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs.
Guo Y; Li Y; Xue L; Severino RP; Gao S; Niu J; Qin LP; Zhang D; Brömme D
J Ethnopharmacol; 2014 Sep; 155(3):1401-16. PubMed ID: 25109459
[TBL] [Abstract][Full Text] [Related]
36. Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.
Yang F; Lin ZW; Huang TY; Chen TT; Cui J; Li MY; Hua YQ
Sci Rep; 2019 May; 9(1):6991. PubMed ID: 31061445
[TBL] [Abstract][Full Text] [Related]
37. Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments.
Zhong Z; Li Y; Chen Y; Chen W; Li S; Lv X; Luo S
Drug Des Devel Ther; 2021; 15():817-827. PubMed ID: 33658763
[TBL] [Abstract][Full Text] [Related]
38. Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis.
Gan D; Xu X; Chen D; Feng P; Xu Z
Med Sci Monit; 2019 Aug; 25():5700-5716. PubMed ID: 31368456
[TBL] [Abstract][Full Text] [Related]
39. Ophiopogonin D: A new herbal agent against osteoporosis.
Huang Q; Gao B; Wang L; Zhang HY; Li XJ; Shi J; Wang Z; Zhang JK; Yang L; Luo ZJ; Liu J
Bone; 2015 May; 74():18-28. PubMed ID: 25582622
[TBL] [Abstract][Full Text] [Related]
40. [Research progress on anti-osteoporotic active ingredients and pharmacological action mechanism of traditional Chinese kidney-tonifying and bone-strengthening drugs].
Li Y; Tong J; Zhou YJ; Xu XY
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1038-43. PubMed ID: 26226741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
